Yahoo Web Search

Search results

1. • 

     1 Wall Street Analyst Thinks Editas Medicine Stock Is Going to $15. Is It a Buy Around $5?

     Motley Fool via Yahoo Finance· 2 weeks ago

     Clinical-stage biotech Editas Medicine (NASDAQ: EDIT) delivered quarterly results that fell well...

2. • 

     Better Gene-Editing Stock: Editas Medicine vs. Bluebird Bio

     Motley Fool· 1 year ago

     Editas Medicine (NASDAQ: EDIT) and Bluebird Bio (NASDAQ: BLUE) are both beaten-down gene-editing...

3. • 

     1 Wall Street Analyst Raises Editas Medicine's Price Target by 45%. Here's Why She's Right.

     Motley Fool via Yahoo Finance· 2 months ago

     With Citigroup analyst Samantha Semenkow calling on Feb. 29 for shares of Editas Medicine (NASDAQ:...

4. • 

     Why Editas Medicine Stock Soared as Much as 42% Higher This Week

     Motley Fool via Yahoo Finance· 3 months ago

     Shares of Editas Medicine (NASDAQ: EDIT) charged sharply higher this week, soaring as much as 41.6%,...

5. • 

     Is Editas Medicine Stock a Buy Now?

     Motley Fool· 1 year ago

     With shares down by 60% in the last three years, Editas Medicine (NASDAQ: EDIT) investors are experiencing a bumpy ride despite the company's impeccable...

6. • 

     Editas Medicine, Inc. (NASDAQ:EDIT) is a favorite amongst institutional investors who own 71%

     Simply Wall St. via Yahoo Finance· 2 weeks ago

     Key Insights Significantly high institutional ownership implies Editas Medicine's stock price is...

7. • 

     Editas Medicine (NASDAQ:EDIT) shareholders have endured a 87% loss from investing in the stock three...

     Simply Wall St. via Yahoo Finance· 4 months ago

     Editas Medicine, Inc. (NASDAQ:EDIT) shareholders should be happy to see the share price up 24% in...

8. • 

     Why Editas Medicine Stock Is Soaring Today

     Motley Fool· 8 months ago

     What happened Shares of Editas Medicine (NASDAQ: EDIT) were soaring 11.2% higher as of 10:41 a.m. ET on Friday after vaulting as much as 24% earlier in...

9. • 

     Where Will Editas Medicine Be in 1 Year?

     Motley Fool· 1 year ago

     Gene-editing specialist Editas Medicine (NASDAQ: EDIT) fits the bill, which is why the company's shares have plunged this year. Could this be what's in...

10. • 

      Strong week for Editas Medicine (NASDAQ:EDIT) shareholders doesn't alleviate pain of five-year loss

      Simply Wall St. via Yahoo Finance· 1 year ago

      Over the last month the Editas Medicine, Inc. (NASDAQ:EDIT) has been much stronger than before,...